Search Within

Daniel Hirschhorn Cymerman

Formats
  1. Journal Article (24)
  2. Meeting Abstract (24)
Groups
  1. Department of Medicine (48)
  2. Sloan Kettering Institute Postdocs (48)
  3. GSK Faculty (47)
  4. Melanoma and Immunotherapeutics Service (46)
  5. Solid Tumor Oncology Division (46)
  6. Hematologic Malignancies, Division of (26)

More Groups

People
  1. Taha Merghoub (42)
  2. Jedd Wolchok (41)
  3. Sadna Budhu (20)
  4. Alan Houghton (19)
  5. Cailian Liu (16)
  6. Roberta Zappasodi (12)

More People

Years
  1. 2023 (1)
  2. 2022 (5)
  3. 2021 (4)
  4. 2020 (2)
  5. 2019 (2)
  6. 2018 (6)

More Years

Publications
  1. Cancer Research (7)
  2. Journal for ImmunoTherapy of Cancer (6)
  3. Journal of Immunology (6)
  4. Blood (4)
  5. Journal of Experimental Medicine (4)
  6. Biology of Blood and Marrow Transplantation (2)

More Publications

Publishers
  1. American Association for Cancer Research (11)
  2. Biomed Central Ltd (6)
  3. The American Association of Immunologists, Inc (6)
  4. American Society of Hematology (4)
  5. Rockefeller University Press (4)
  6. Cell Press (3)

More Publishers

Results (48)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • T cell immunotherapies trigger innate immunity and aseptic inflammation leading to potent anti-tumor and off-targets effects
    Meeting Abstract

    Hirschhorn, D.; Ricca, J.; Gasmi, B.; Mangarin, L. M.; De Henau, O.; Budhu, S.; Li, Y.; Cortez, C.; Xia, Y.; Zhong, H.; more...
    Journal for ImmunoTherapy of Cancer (2017)

    Fulltext@MSK | Save
  • Opposing effects of CTLA-4 and PD-1 blockade on follicular helperlike T cells with immunosuppressive functions
    Meeting Abstract

    Zappasodi, R.; Budhu, S.; Hellmann, M. D.; Postow, M.; Senbabaoglu, Y.; Gasmi, B.; Zhong, H.; Li, Y.; Liu, C.; Hirschhorhn-Cymerman, D.; more...
    Journal for ImmunoTherapy of Cancer (2016)

    Fulltext@MSK | Save
  • Overcoming resistance to checkpoint blockade therapy by targeting PI3Kγ in myeloid cells
    Journal Article

    De Henau, O.; Rausch, M.; Winkler, D.; Campesato, L. F.; Liu, C.; Cymerman, D. H.; Budhu, S.; Ghosh, A.; Pink, M.; Tchaicha, J.; more...
    Nature (2016)

    Fulltext@MSK | Save
  • The new era of cancer immunotherapy: Manipulating T-cell activity to overcome malignancy
    Journal Article

    Khalil, D. N.; Budhu, S.; Gasmi, B.; Zappasodi, R.; Hirschhorn-Cymerman, D.; Plitt, T.; De Henau, O.; Zamarin, D.; Holmgaard, R. B.; Murphy, J. T.; more...
    Advances in Cancer Research (2015)

    Fulltext@MSK | Save
  • Combination of alphavirus replicon particle-based vaccination with immunomodulatory antibodies: Therapeutic activity in the B16 melanoma mouse model and immune correlates
    Journal Article

    Avogadri, F.; Zappasodi, R.; Yang, A.; Budhu, S.; Malandro, N.; Hirschhorn-Cymerman, D.; Tiwari, S.; Maughan, M. F.; Olmsted, R.; Wolchok, J. D.; more...
    Cancer Immunology Research (2014)

    Fulltext@MSK | Save
  • Enhancement of tumor-reactive cytotoxic CD4(+) T-cell responses after ipilimumab treatment in four advanced melanoma patients
    Journal Article

    Kitano, S.; Tsuji, T.; Liu, C.; Hirschhorn-Cymerman, D.; Kyi, C.; Mu, Z.; Allison, J. P.; Gnjatic, S.; Yuan, J. D.; Wolchok, J. D.
    Cancer Immunology Research (2013)

    Fulltext@MSK | Save
  • OX40 engagement promotes potent tumoricidial CD4+T cells
    Meeting Abstract

    Hirschhorn-Cymerman, D.; Budhu, S.; Kitano, S.; Merghoub, T.; Wolchok, J.
    Journal of Immunology (2013)

    Fulltext@MSK | Save
  • Agonist antibodies to TNFR molecules that costimulate T and NK cells
    Journal Article

    Melero, I.; Hirschhorn-Cymerman, D.; Morales-Kastresana, A.; Sanmamed, M. F.; Wolchok, J. D.
    Clinical Cancer Research (2013)

    Fulltext@MSK | Save
  • Induction of tumoricidal function in CD4+ T cells is associated with concomitant memory and terminally differentiated phenotype
    Journal Article

    Hirschhorn-Cymerman, D.; Budhu, S.; Kitano, S.; Liu, C.; Zhao, F.; Zhong, H.; Lesokhin, A. M.; Avogadri Connors, F.; Yuan, J.; Li, Y.; more...
    Journal of Experimental Medicine (2012)

    Fulltext@MSK | Save
  • Monocytic CCR2(+) myeloid-derived suppressor cells promote immune escape by limiting activated CD8 T-cell infiltration into the tumor microenvironment
    Journal Article

    Lesokhin, A. M.; Hohl, T. M.; Kitano, S.; Cortez, C.; Hirschhorn-Cymerman, D.; Avogadri, F.; Rizzuto, G. A.; Lazarus, J. J.; Pamer, E. G.; Houghton, A. N.; more...
    Cancer Research (2012)

    Fulltext@MSK | Save